"In September 2021, a CDC report found that hospital-acquired infections have increased significantly in 2020 after years of steady decline. Standard infection prevention practices have been impacted by staffing shortages and chaotic work environments, which has subsequently created an environment that is susceptible for diagnostic errors. These factors indicate a troubling trend working against antimicrobial and diagnostic stewardship efforts.

As a result, hospital and healthcare system leaders are re-focusing their attention on patient safety and quality outcomes—and trying to solve the problems of blood culture contamination, which can lead to a misdiagnosis of sepsis. With those goals in mind, a new webinar from Dark Daily will focus on practical and effective solutions designed to reduce the risk of antibiotic-related infections, antimicrobial resistance, and false-positive blood cultures.

Featuring a case study and live Q&A, the webinar will review the quality improvement (QI) project of a 425-bed academic medical center. We will examine the impact of a 90% reduction in blood culture contamination rates and the direct effect on antimicrobial stewardship efforts which resulted in a 31% reduction in vancomycin days of therapy (DOT)."

"While the term 'AI' is thrown around freely, do you really know why it’s needed? Learn about existing AI-based applications across broad range of modalities from head to toe. Then hear about current limitations and future developments in this growing field."

NOTE: "SIIM Members are eligible to receive 1.0 hour SIIM IIP CE towards ABII certification and recertification for the live as well as the recorded webinar. Non-members can earn 1.0 hour SIIM IIP CE by purchasing the webinar for $25."

"In this session, we will review current laboratory practices used in the diagnosis and treatment of diabetes and associated metabolic conditions. We will also explore new diagnostic tools and preventative therapies to reverse the epidemic trend in the United States.

Learning Objectives

* Generalize the recent trend in diagnosed diabetes mellitus cases, including contributing factors such as COVID.
* Review current classification of diabetes mellitus, American Diabetes Association’s diagnostic criteria and testing methods.
* Describe emerging diagnostic tools, therapeutics, and preventative treatments for pre-diabetes, diabetes, and its related disorders."

Date:  Wednesday, May 25, 2022, 2:30 pm ET Company: ResultWorks Presenter: Bob O’Hara, Vice President, ResultWorks Overview: Paragraph or two about your problem statement for the webcast. The personalized nature of cell therapies means that organizations are required by regulators to demonstrate end-to-end visibility across the product supply chain, ensuring chain of custody, identity, and condition. […]